View in EDS HTML Full Text PDF Full Text

Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors.

Saved in:
Bibliographic Details
Title: Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors.
Authors: Mapelli, Paola1,2 (AUTHOR), Bezzi, Carolina1,2 (AUTHOR), Muffatti, Francesca3 (AUTHOR), Ghezzo, Samuele1,2 (AUTHOR), Baldassi, Francesco4 (AUTHOR), Schiavo Lena, Marco5 (AUTHOR), Andreasi, Valentina1,3 (AUTHOR), Canevari, Carla2 (AUTHOR), Magnani, Patrizia2 (AUTHOR), De Cobelli, Francesco1,6 (AUTHOR), Gianolli, Luigi2 (AUTHOR), Partelli, Stefano1,3 (AUTHOR), Falconi, Massimo1,3 (AUTHOR), Picchio, Maria1,2 (AUTHOR) picchio.maria@hsr.it
Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2023, Vol. 50 Issue 9, p2818-2829. 12p. 2 Color Photographs, 5 Charts, 3 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16197070
DOI:10.1007/s00259-023-06210-7